Modified Botox Offers Safe and Effective Long-Term Pain Relief for Nerve Injury Patients.
Scientists from the Universities of Sheffield, Reading, and University College London, along with US-based biopharmaceutical company Neuresta, have developed an elongated botulinum neurotoxin that can alleviate chronic pain without causing addiction or nerve damage leading to paralysis. The new drug provides long-lasting relief in mice models without adverse effects and could potentially relieve pain for many months in humans. The team hopes that the engineered drug could improve the quality of life for the millions of people worldwide who suffer from chronic pain.